Adaptive Biotechnologies said management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York on September 15, 2026. The presentation is scheduled for 4:50 p.m. ET, or 1:50 p.m. PT. A live and archived webcast will be available through the Investors section of the company’s website. Adaptive Biotechnologies (Nasdaq: ADPT) uses a proprietary immune medicine platform to decode the genetics of the adaptive immune system and develop clinical products across its Minimal Residual Disease and Immune Medicine segments. Its commercial products and clinical pipeline support the diagnosis, monitoring and treatment of diseases including cancer and autoimmune disorders.